Non-promotional communication in a pharmaceutical company
At present, pharmaceutical companies use a wide variety of communication channels to reach a whole diversity of recipients: conferences, arti-cels, social networks, websites, mailing lists, etc. As a result, it is now more difficult to control the content of such communication. In particular, there is risk that medical community is getting increasingly exposed to promotional information on off-label indications and/or products.